Cargando…

Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose

The present study evaluates the adverse effects of three vaccines: AstraZeneca (Vaxzevria), Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) according to the dose. From 733 participants collected, the vaccine schedule was as follows: 330 (45%) received a double dose of the AstraZeneca vaccine, 382...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ríos, Esther, Medrano, Sara, Martínez, Mercedes, Novella, Consuelo, Marcos, Esther, Fernández, Jose J., Delgado-Iribarren, Alberto, Culebras, Esther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504129/ https://www.ncbi.nlm.nih.gov/pubmed/36146475 http://dx.doi.org/10.3390/vaccines10091397

Ejemplares similares

Valoración de dos pruebas inmunocromatográficas para la detección de anticuerpos frente a SARS-CoV-2
por: Medrano, Sara, et al.
Publicado: (2022)

High performance of the automated ADVIA Centaur Systems SARS-CoV-2 Antigen Assay in nasopharyngeal samples with high viral load
por: Ríos, Esther, et al.
Publicado: (2022)

Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection
por: Baos, Elvira, et al.
Publicado: (2022)

Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents
por: Rodríguez-Avial, Iciar, et al.
Publicado: (2023)

Role of Hologic® Panther Aptima™ SARS-CoV-2 assay in the detection of SARS-CoV-2: screening or diagnostic technique?
por: García-Salguero, Cristina, et al.
Publicado: (2023)

Utilidad de MALDI-TOF y REP-PCR frente a PFGE para el estudio epidemiológico de Acinetobacter baumannii
por: García-Salguero, Cristina, et al.
Publicado: (2021)

Delayed large local reactions to Moderna COVID-19 vaccine: A follow-up report after booster vaccination
por: Blumenthal, Kimberly G., et al.
Publicado: (2022)

Citizen Stance towards Mandatory COVID-19 Vaccination and Vaccine Booster Doses: A Study in Colombia, El Salvador and Spain
por: Iguacel, Isabel, et al.
Publicado: (2022)

Booster or additional vaccination doses in patients vaccinated against COVID-19
por: García-Botella, Alejandra, et al.
Publicado: (2021)

Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters
por: Strahan, Alexis, et al.
Publicado: (2022)

Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain
por: Benitez Fuentes, Javier David, et al.
Publicado: (2022)

Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli
por: Ríos, Esther, et al.
Publicado: (2022)

The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose
por: Chen, Liling, et al.
Publicado: (2023)

Immunogenicity of a BNT162b2 vaccine booster in health-care workers
por: Saiag, Esther, et al.
Publicado: (2021)

Association between the Mediterranean lifestyle, metabolic syndrome and mortality: a whole-country cohort in Spain
por: Sotos-Prieto, Mercedes, et al.
Publicado: (2021)

COVID-19 vaccine equity and booster doses
por: The Lancet Infectious Diseases
Publicado: (2021)

COVID vaccine booster doses for omicron variants
por: Burki, Talha
Publicado: (2022)

Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study
por: Ferrara, Pietro, et al.
Publicado: (2023)

Serological Tests in the Detection of SARS-CoV-2 Antibodies
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2021)

Prevertebral Inflammatory Myofibroblastic Tumor Following COVID Vaccine Booster Dose
por: Sprenger, Flávia, et al.
Publicado: (2023)

COVID-19 Vaccination in China: Adverse Effects and Its Impact on Health Care Working Decisions on Booster Dose
por: Luo, Chengwen, et al.
Publicado: (2022)

Booster dose after 10 years is recommended following 17DD-YF primary vaccination
por: Campi-Azevedo, Ana Carolina, et al.
Publicado: (2015)

Safety of seven COVID-19 vaccine booster doses
Publicado: (2021)

Interim statement on covid-19 vaccine booster doses
Publicado: (2021)

Myopericarditis After COVID-19 Booster Dose Vaccination
por: Sharff, Katie A., et al.
Publicado: (2022)

Interim statement on covid-19 vaccine booster doses
Publicado: (2021)

COVID-19 in solid organ transplant recipients: A single-center case series from Spain
por: Fernández-Ruiz, Mario, et al.
Publicado: (2020)

Risk Factors and Incidence Rates of Self-Reported Short-Term Adverse Events of COVID-19 Vaccine Booster Dose
por: Chen, Po-Yu, et al.
Publicado: (2022)

Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel
por: Hidayat, Rakhmad, et al.
Publicado: (2022)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

Comparative study of different SARS-CoV-2 diagnostic techniques
por: Vallejo, L., et al.
Publicado: (2021)

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru
por: Bendezu-Quispe, Guido, et al.
Publicado: (2022)

Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System
por: Ruiz, Federico M., et al.
Publicado: (2015)

Correction: Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System
por: Ruiz, Federico M., et al.
Publicado: (2015)

Dietary Zinc and Risk of Prostate Cancer in Spain: MCC-Spain Study
por: Gutiérrez-González, Enrique, et al.
Publicado: (2018)

Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain
por: Mallah, Narmeen, et al.
Publicado: (2022)

Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review
por: Artime, Esther, et al.
Publicado: (2021)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Rzymski, Piotr, et al.
Publicado: (2021)

Efficacy of COVID-19 vaccine booster doses in older people
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ht2c2f8bhp5p7j0f38rjejaeb0